论文部分内容阅读
目的:探讨腹腔镜下行结肠癌根治术与肝转移灶切除术的安全性及疗效。方法:选择2009年3月―2011年4月收治的50例结肠癌同时性肝转移患者,其中25例患者行腹腔镜下结肠癌根治术及肝转移灶切除术(腹腔镜组),另25例在传统开腹手术(开腹组)。比较两组患者的术中情况、术后恢复情况以及术后1、2、3年生存率。结果:腹腔镜组的术中出血量、术后镇痛时间、排气时间、住院时间及并发症均明显少于开腹组(P<0.05),但两组的手术时间差异无统计学意义(P>0.05)。两组患者术后1、2、3年生存率差异无统计学意义(均P>0.05)。结论:完全腹腔镜治疗结肠癌伴同时性肝转移安全可行,与开腹手术疗效相同,同时具有创伤小、术后恢复快、并发症少等优点。
Objective: To investigate the safety and efficacy of laparoscopic radical mastectomy and hepatic metastasis resection. Methods: Fifty patients with concurrent liver metastases from March 2009 to April 2011 were selected. Among them, 25 patients underwent laparoscopic radical resection of colon cancer and resection of liver metastases (laparoscopic group), and another 25 Cases of open surgery in the traditional (open group). The intraoperative conditions, postoperative recovery and postoperative 1, 2, 3 year survival rates were compared between the two groups. Results: The intraoperative blood loss, postoperative analgesia time, exhaust time, hospitalization time and complications in the laparoscopic group were significantly less than those in the laparotomy group (P <0.05), but there was no significant difference in operative time between the two groups (P> 0.05). There was no significant difference in the 1, 2, 3 year survival rates between the two groups (all P> 0.05). Conclusion: Laparoscopic treatment of colon cancer with simultaneous liver metastasis is safe and feasible, which has the same curative effect as laparotomy. It also has the advantages of less trauma, faster recovery and fewer complications.